Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes
Diabetes Technology & Therapeutics · 2024
DOI: 10.1089/dia.2023.0594 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes Technology & Therapeutics, 2024. Verfasst von Carmen Quirós und 23 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Hospital Universitari Mútua de Terrassa, Terrassa, Spain. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Hypoglycemic Agents, Pregnancy in Diabetics. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Department, Hospital Universitari Mútua de Terrassa, Terrassa, Spain.
- Endourology Department, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
- Endourology Department, Hospital Universitari Vall Hebrón, Barcelona, Spain.
- Endourology Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Canarias, Universidad de Las Palmas de Gran Canaria, Gran Canaria, Spain.
- Hospital Universitario de Badajoz, Badajoz, Spain.
- Hospital Infanta Sofía, Madrid, Spain.
ORCID-Profile: Carmen Quirós, María Teresa Herrera Arranz, Judit Amigó, Ana M Wägner, Pilar I Beato-Vibora, Sharona Azriel-Mira, Elisenda Climent, Berta Soldevila, Beatriz Barquiel, Natalia Colomo, Rosa Corcoy, Mercedes Codina, Gonzalo Díaz-Soto, Rosa Márquez Pardo, Maria A Martínez-Brocca, Ángel Rebollo Román, Gema López-Gallardo, Martín Cuesta, Javier García Fernández, Maria Goya, Begoña Vega Guedes, Lillian C Mendoza Mathison, Verónica Perea
Zitieren
APA
Quirós, C., Herrera Arranz, M. T., Amigó, J., Wägner, A. M., Beato-Vibora, P. I., Azriel-Mira, S., Climent, E., Soldevila, B., Barquiel, B., Colomo, N., Durán-Martínez, M., Corcoy, R., Codina, M., Díaz-Soto, G., Márquez Pardo, R., Martínez-Brocca, M. A., Rebollo Román, Á., López-Gallardo, G., Cuesta, M., …, & Perea, V. (2024). Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2023.0594
Vancouver
Quirós C, Herrera Arranz MT, Amigó J, Wägner AM, Beato-Vibora PI, Azriel-Mira S, et al. Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technology & Therapeutics. 2024. doi:10.1089/dia.2023.0594
BibTeX
@article{Quirs2024,
author = {Quirós, Carmen and Herrera Arranz, María Teresa and Amigó, Judit and Wägner, Ana M and Beato-Vibora, Pilar I and Azriel-Mira, Sharona and Climent, Elisenda and Soldevila, Berta and Barquiel, Beatriz and Colomo, Natalia and Durán-Martínez, María and Corcoy, Rosa and Codina, Mercedes and Díaz-Soto, Gonzalo and Márquez Pardo, Rosa and Martínez-Brocca, Maria A and Rebollo Román, Ángel and López-Gallardo, Gema and Cuesta, Martín and García Fernández, Javier and Goya, Maria and Vega Guedes, Begoña and Mendoza Mathison, Lillian C and Perea, Verónica},
title = {Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes},
journal = {Diabetes Technology & Therapeutics},
year = {2024},
doi = {10.1089/dia.2023.0594}
}
EUVIMED